Cargando…
Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases
The polyglutamine (polyQ) diseases are a group of inherited neurodegenerative diseases caused by the abnormal expansion of a CAG trinucleotide repeat that are translated into an expanded polyQ stretch in the disease-causative proteins. The expanded polyQ stretch itself plays a critical disease-causa...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907447/ https://www.ncbi.nlm.nih.gov/pubmed/33642983 http://dx.doi.org/10.3389/fnins.2021.621996 |